Education
About Us
Working with TipRanks
Follow Us
Marizyme (MRZM)
:MRZM
Total Valuation
Marizyme has a market cap or net worth of $39.54K. The enterprise value is $26.63M.
Market Cap$39.54K
Enterprise Value$26.63M
Share Statistics
Marizyme has 131,793,090 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding131,793,090
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Marizyme’s return on equity (ROE) is 14.92 and return on invested capital (ROIC) is -186.37%.
Return on Equity (ROE)14.92
Return on Assets (ROA)-3.16
Return on Invested Capital (ROIC)-186.37%
Return on Capital Employed (ROCE)54.31
Revenue Per Employee49.68K
Profits Per Employee-5.35M
Employee Count13
Asset Turnover0.03
Inventory Turnover16.37
Valuation Ratios
The current PE Ratio of Marizyme is -0.07. Marizyme’s PEG ratio is >-0.01.
PE Ratio-0.07
PS Ratio0.00
PB Ratio>-0.01
Price to Fair Value-0.98
Price to FCF-0.01
Price to Operating Cash Flow-0.01
PEG Ratio>-0.01
Income Statement
In the last 12 months, Marizyme had revenue of 645.81K and earned -69.54M in profits. Earnings per share was -1.53.
Revenue645.81K
Gross Profit238.91K
Operating Income-34.09M
Pretax Income-65.35M
Net Income-69.54M
EBITDA-55.44M
Earnings Per Share (EPS)-1.53
Cash Flow
In the last 12 months, operating cash flow was -3.84M and capital expenditures 0.00, giving a free cash flow of -3.84M billion.
Operating Cash Flow-3.84M
Free Cash Flow-3.84M
Free Cash Flow per Share-0.03
Dividends & Yields
Marizyme pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta9.63
52-Week Price Change0.00%
50-Day Moving Average0.05
200-Day Moving Average0.04
Relative Strength Index (RSI)61.86
Average Volume (3m)0.00
Important Dates
Marizyme upcoming earnings date is Dec 23, 2021, TBA (Confirmed).
Last Earnings DateInvalid Date
Next Earnings DateDec 23, 2021
Ex-Dividend Date―
Financial Position
Marizyme as a current ratio of 0.04, with Debt / Equity ratio of -171.55%
Current Ratio0.04
Quick Ratio0.04
Debt to Market Cap4.32
Net Debt to EBITDA-0.37
Interest Coverage Ratio-1.13
Taxes
In the past 12 months, Marizyme has paid 4.19M in taxes.
Income Tax4.19M
Effective Tax Rate-0.06
Enterprise Valuation
Marizyme EV to EBITDA ratio is -0.45, with an EV/FCF ratio of -5.37.
EV to Sales38.95
EV to EBITDA-0.45
EV to Free Cash Flow-5.37
EV to Operating Cash Flow-5.37
Balance Sheet
Marizyme has $63.73K in cash and marketable securities with $26.66M in debt, giving a net cash position of $26.59M billion.
Cash & Marketable Securities$63.73K
Total Debt$26.66M
Net Cash$26.59M
Net Cash Per Share$0.20
Tangible Book Value Per Share-$0.58
Margins
Gross margin is -281.66%, with operating margin of -5278.10%, and net profit margin of -10767.77%.
Gross Margin-281.66%
Operating Margin-5278.10%
Pretax Margin-10118.60%
Net Profit Margin-10767.77%
EBITDA Margin-8585.15%
EBIT Margin-8715.41%
Analyst Forecast
The average price target for Marizyme is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―